Place it in its market
Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.
See how Context works →On the price, the facts of the public record■Insider buy□Insider sell◇Significant stake declared (13D)●Results filed
With an account, also○dividends▲splits◌next earningswith an account
End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.
Latest on record
The most recent facts, as filed.
Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.
- Aug 27, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
- Aug 17, 2026Notice of sale · Form 144Hawryluk P. Kent · Former Officer · $255.7KOpen the filing ↗
- Aug 6, 2026Quarterly report · 10-QFiled by the company itself.Open the filing ↗
In numbers
What this profile holds, counted.
Closes · 1 year250
SEC filings on record20627 flagged findings
Reported transactions (Form 4)80since Sep 16, 2024 · and 40 other holdings
Corporate events (8-K)9since Apr 7, 2025
What the record says
Description, identity and filings, each with its source.
Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.
Regulatory history
Topics detected in its SEC reports, with the original excerpt.
Each topic is assigned by a classifier over the full filing; the excerpts show where it was detected and are not always enough to verify it. Open the filing to read it in full.
- 2026-05-07share offering or dilution eventrecentOpen filing ↗“…and diluted $ ( 0.50 ) $ ( 0.71 ) Weighted average number of common shares outstanding used in computation of net loss per common…”
+1 more passage from the same document
- “…and providing general and administrative support for these operations. The Company does not have any products approved for sale…”
- 2026-05-07capital return (buybacks/dividends)recentOpen filing ↗“…current assets 448,536 381,539 Property and equipment, net 3,133 2,735 Right-of-use assets 453 487 Other assets 579 383 Total assets…”
+1 more passage from the same document
- “…assets 448,536 381,539 Property and equipment, net 3,133 2,735 Right-of-use assets 453 487 Other assets 579 383 Total assets $…”
- 2026-03-12share offering or dilution eventrecentOpen filing ↗“…or any other securities exchange or quotation or trading service on which such securities may be listed, quoted or traded at the…”
- 2026-03-12capital return (buybacks/dividends)recentOpen filing ↗“…and together with all other information included and incorporated by reference in this prospectus supplement, before investing in…”
+1 more passage from the same document
- “…for illustration purposes only and will adjust based on the actual price at which shares of our common stock are sold. The foregoing…”
Original excerpts from SEC filings, untranslated. Not advice and not a prediction.
The 25 most recent filings (of 206)
Every SEC filing, newest first, with what it is. Below, each type with its own explanation.
- Aug 27, 268-K ↗Current report · Communication to the market · Other events
- Aug 17, 26Form 144 ↗Notice of proposed sale
- Aug 14, 26SCHEDULE 13G/A ↗Passive stake · Deep Track Capital, LP · 3.6% · event on Jun 30, 26 · amendment
- Aug 10, 26SCHEDULE 13D/A ↗Stake with intent to influence · James N. Topper · 11.7% · event on Aug 6, 26 · amendment
- Aug 10, 26SCHEDULE 13D/A ↗Stake with intent to influence · ORBIMED ADVISORS LLC · 6.4% · event on Aug 6, 26 · amendment
- Aug 6, 2610-Q ↗Quarterly report
- Aug 6, 268-K ↗Current report · Results · Communication to the market · Other events
- Aug 5, 26Form 4 ↗Insider transaction
Notice of proposed sale · 2 Form 144 filingsshow all 2hide
- Aug 4, 26Form 144 ↗Notice of proposed sale
- Aug 4, 26Form 144 ↗Notice of proposed sale
- Jul 29, 26SCHEDULE 13G ↗Passive stake · BlackRock, Inc. · 5.5% · event on Jun 30, 26
- Jul 13, 268-K ↗Current report · A senior executive left or was appointed
- Jul 8, 26SCHEDULE 13G/A ↗Passive stake · Wellington Management Group LLP · 10.5% · event on Jun 30, 26 · amendment
- Jul 8, 26SCHEDULE 13G/A ↗Passive stake · FMR LLC · 11.2% · event on Jun 30, 26 · amendment
- Jun 24, 26SCHEDULE 13G ↗Passive stake · Paradigm BioCapital Advisors LP · 5.2% · event on Jun 16, 26
- Jun 12, 268-K ↗Current report · Communication to the market · Other events
Notice of proposed sale · 2 Form 144 filingsshow all 2hide
- Jun 10, 26Form 144 ↗Notice of proposed sale
- Jun 9, 26Form 144 ↗Notice of proposed sale
206 filings on record, the oldest from Apr 17, 24.
Listing the 25 most recent filings of the 206 on record.
27
- Jul 13, 26A senior executive left or was appointed8-K 5.02 ↗
- Jun 5, 26A senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
- Feb 27, 26Entered a material agreement+2 more in the same filing8-K 1.01 ↗
- Jan 22, 26A senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
- Nov 6, 25A senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
- Sep 26, 25Entered a material agreement+1 more in the same filing8-K 1.01 ↗
- Jun 6, 25A senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
- Apr 7, 25A senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.
Schedule 13D: stake and stated purpose
Filed by holders above 5% of a share class who cannot use the short form. It includes the investor's stated purpose: read it before assuming they seek influence.
- James N. Topper11.7%Aug 6, 26SCHEDULE 13D/A ↗11 co-filers on this document — the figure is the largest single stake, not their sum.
- Frazier Life Sciences X, L.P.11.7%Sep 26, 25SCHEDULE 13D/A ↗14 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
- New Enterprise Associates 17, L.P.8.1%Nov 6, 25SCHEDULE 13D/A ↗12 co-filers on this document — the figure is the largest single stake, not their sum.
- ORBIMED ADVISORS LLC6.4%Aug 6, 26SCHEDULE 13D/A ↗3 co-filers on this document — the figure is the largest single stake, not their sum. · 2 earlier filings
- Norwest Venture Partners XVI, LP4.8%Sep 26, 25SCHEDULE 13D/A ↗6 co-filers on this document — the figure is the largest single stake, not their sum.
Schedule 13G: short-form filing
The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.
- FMR LLC11.2%Jun 30, 26SCHEDULE 13G/A ↗2 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
- Wellington Management Group LLP10.5%Jun 30, 26SCHEDULE 13G/A ↗4 co-filers on this document — the figure is the largest single stake, not their sum. · 4 earlier filings
- BlackRock, Inc.5.5%Jun 30, 26SCHEDULE 13G ↗2 earlier filings
- Paradigm BioCapital Advisors LP5.2%Jun 16, 26SCHEDULE 13G ↗4 co-filers on this document — the figure is the largest single stake, not their sum.
- Wellington Biomedical Innovation Master Investors (Cayman) II, L.P.4.5%Sep 30, 25SCHEDULE 13G/A ↗
show 2 more holdershide
- P. Kent Hawryluk4.3%Sep 30, 25SCHEDULE 13G/A ↗
- Deep Track Capital, LP3.6%Jun 30, 26SCHEDULE 13G/A ↗3 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.
Sale intention announced
On Aug 17, Hawryluk P. Kent filed notice of intent to sell up to $256K.
A notice is not a sale: it may not go ahead, may happen in part, or at a different price.
No sale of theirs is on record yet in Form 4; the 90-day window is still open.
View notice (Form 144) ↗+2 more recent notices · 1 with a later sale
- Aug 4, 26Sell$24KSalomon AzoulayChief Medical Officer↗
- May 8, 26Sell$2.1MSalomon AzoulayChief Medical Officer↗
- May 8, 26Sell$575KSalomon AzoulayChief Medical Officer↗
- May 6, 26Sell$18KP. Kent HawrylukPresident & CEO↗
- May 6, 26Sell$7KSalomon AzoulayChief Medical Officer↗
- Mar 13, 26Buy$526KP. Kent HawrylukPresident & CEO↗
- Oct 20, 25Buy$273KP. Kent HawrylukPresident & CEO↗
- Oct 17, 25Buy$265KSteven L. Hoerter↗
- Sep 26, 25Buy$12.0MPatrick J Heron↗
- Apr 8, 25Buy$45KOra H. Pescovitz↗
- Feb 18, 25Buy$532KORBIMED ADVISORS LLC↗
- Feb 18, 25Buy$1.0MORBIMED ADVISORS LLC↗
There are 8 more transactions in this stretch.
Stock compensation, tax and giftsshow the 20 other transactionshide
Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.
- Aug 3, 26Compensationamount n/aSteven L. HoerterPresident and CEO↗
- Aug 3, 26Compensationamount n/aJohn W SmitherChief Financial Officer↗
- May 8, 26Compensation$575KSalomon AzoulayChief Medical Officer↗
- May 8, 26Compensation$240KSalomon AzoulayChief Medical Officer↗
- May 1, 26Compensationamount n/aSteven L. Hoerter↗
- Feb 26, 26Compensation$460KP. Kent HawrylukPresident & CEO↗
- Feb 2, 26Compensationamount n/aP. Kent HawrylukPresident & CEO↗
- Feb 2, 26Compensationamount n/aRichard BartramChief Financial Officer↗
- Feb 2, 26Compensationamount n/aSalomon AzoulayChief Medical Officer↗
- Oct 24, 25Compensation$594KP. Kent HawrylukPresident & CEO↗
- Sep 16, 24Otheramount n/aORBIMED ADVISORS LLC↗
- Sep 16, 24Otheramount n/aORBIMED ADVISORS LLC↗
- Sep 16, 24Otheramount n/aWellington Biomedical Innovation Master Investors (Cayman) II L.P.↗
- Sep 16, 24Otheramount n/aWellington Biomedical Innovation Master Investors (Cayman) II L.P.↗
- Sep 16, 24Otheramount n/aTiba Aynechi↗
- Sep 16, 24Otheramount n/aP. Kent HawrylukPresident & CEO↗
- Sep 16, 24Otheramount n/aP. Kent HawrylukPresident & CEO↗
- Sep 16, 24Otheramount n/aPatrick J Heron↗
- Sep 16, 24Otheramount n/aJAMES M CORNELIUS↗
- Sep 16, 24Otheramount n/aFrazier Life Sciences X, L.P.↗
The full record holds 70 transactions and goes back to Sep 12, 24.
Its sector and its market
MBX Biosciences, Inc. among Health Care companies
The profile shows what is on record. Context and Radar place the company among those of its sector and region.
Browse its neighbours
Other Health Care companies
With an account you also get
- The four engines — growth, trend, risk and context — each with its word and its score.
- The risk band and the sector phase.
- The company's fundamentals and accounts.
- Watchlist: your list of companies, with the «since you follow it» figure.
The research continues
The profile tells the story. The market sets the scene.
From MBX Biosciences, Inc., the path continues in the other areas. Each one is shown with its own example, named in its step.
See what deserves a closer look
Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.
See how Radar works →Keep the why
Follow MBX Biosciences, Inc. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.
See an example review →
Coverage
What sits behind this page.
Where each figure comes from and how far it reaches.
- Prices
- End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
- Series quality
- 250 clean closes in the period.
- SEC records
- 206 documents on file, from Apr 17, 2024 to Aug 27, 2026.
- Company description
- No description available.
- This page
- Generated on Oct 18, 2026; refreshed through the day.
Start at your own pace
Explore first. Go deeper with access.
Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.
Compare plans →- No account
This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.
- Pro
What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.
- Pro+
Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.
Are the prices real time?
No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.
Which SEC documents appear here?
Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.
Why does a European company show no SEC records?
It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.
Before forming a view on a company,
read what is on record.
One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.